Utah Medical Products, Inc.UTMDNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P18
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -8.98% |
| Q3 2025 | 32.29% |
| Q2 2025 | 21.91% |
| Q1 2025 | -81.37% |
| Q4 2024 | 331.16% |
| Q3 2024 | -14.05% |
| Q2 2024 | 50.51% |
| Q1 2024 | -87.66% |
| Q4 2023 | 575.29% |
| Q3 2023 | 4.14% |
| Q2 2023 | 24.31% |
| Q1 2023 | -88.77% |
| Q4 2022 | 283.33% |
| Q3 2022 | -0.88% |
| Q2 2022 | 2.46% |
| Q1 2022 | -74.86% |
| Q4 2021 | 303.41% |
| Q3 2021 | -1.52% |
| Q2 2021 | 128.62% |
| Q1 2021 | -88.86% |
| Q4 2020 | 307.68% |
| Q3 2020 | -2.52% |
| Q2 2020 | 0.67% |
| Q1 2020 | -74.96% |
| Q4 2019 | 293.85% |
| Q3 2019 | -0.96% |
| Q2 2019 | 13.65% |
| Q1 2019 | 48.49% |
| Q4 2018 | -3.48% |
| Q3 2018 | -1.49% |
| Q2 2018 | -1.47% |
| Q1 2018 | 2.62% |
| Q4 2017 | 4.49% |
| Q3 2017 | -1.49% |
| Q2 2017 | 2.84% |
| Q1 2017 | -0.94% |
| Q4 2016 | 0.41% |
| Q3 2016 | -6.44% |
| Q2 2016 | 0.94% |
| Q1 2016 | -8.72% |